Included in this prospective study cohort were all patients with CBDS and gallbladder stones treated with laparoscopic common bile duct stone extraction (LCBDE) at the Nanjing Drum Tower Hospital ...

SCG-101 is under clinical development by SCG Cell Therapy and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to GlobalData, Phase II drugs for Bile Duct Cancer ...

Doctors in the UK are hoping to transform the lives of people with deadly bile duct cancer. A new study – which has shown promising early results – matches the patient’s tumour to one or ...

FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim. According to data from Cancer Research UK, up to 70 per cent of all these ...

Consultant medical oncologist Professor John Bridgewater is leading the UK arm of an international study to find treatments for bile duct cancer (Charlotte Southall/UCLH/PA) Doctors in the UK are ...

Background: Patients with pancreatic ductal adenocarcinoma (PDAC) face a highly unfavorable outcome and have a poor response to standard treatments. Immunotherapy, especially therapy based on natural ...

Bile duct cancer, or cholangiocarcinoma, is a malignant tumour of either the bile ducts within the liver (intrahepatic), or those leading from the liver to the small intestine (extrahepatic).